Inventor
CHACKALAMANNIL SAMUEL
US77 patents
⚠️ This page may combine multiple inventors who share the name “CHACKALAMANNIL SAMUEL”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
SCHERING CORP
40 patentsUS6821978B2Nov 23, 2004
Xanthine phosphodiesterase V inhibitors
SCHERING CORP140 citations99
US6645987B2Nov 11, 2003
Nor-seco himbacine derivatives useful as thrombin receptor antagonists
SCHERING CORP97 citations98
US6063847AMay 16, 2000
Thrombin receptor antagonists
SCHERING CORP180 citations98
US5977138ANov 2, 1999
Ether muscarinic antagonists
SCHERING CORP99 citations98
US5883096AMar 16, 1999
Muscarinic antagonists
SCHERING CORP164 citations98
US6326380B1Dec 4, 2001
Thrombin receptor antagonists
SCHERING CORP103 citations97
US6037352AMar 14, 2000
Muscarinic antagonists
SCHERING CORP90 citations97
US5889006AMar 30, 1999
Muscarinic antagonists
SCHERING CORP123 citations97
US7304078B2Dec 4, 2007
Thrombin receptor antagonists
SCHERING CORP43 citations96
US6630475B2Oct 7, 2003
Adenosine A2a receptor antagonists
SCHERING CORP53 citations95
US6043255AMar 28, 2000
Muscarinic antagonists
SCHERING CORP50 citations95
US6969719B2Nov 29, 2005
Polycyclic guanine phosphodiesterase V inhibitors
SCHERING CORP59 citations94
US7776889B2Aug 17, 2010
Spirocyclic thrombin receptor antagonists
SCHERING CORP20 citations92
US7037920B2May 2, 2006
Substituted tricyclic himbacine derivatives that are useful as thrombin receptor antagonists
SCHERING CORP52 citations92
US6897217B2May 24, 2005
2-Alkynyl-and 2-alkenyl-pyrazolo-[4,3-e]-1,2,4-triazolo-[1,5-c]-pyrimidine adenosine A2a receptor antagonists
SCHERING CORP25 citations92
US6894065B2May 17, 2005
Thrombin receptor antagonists
SCHERING CORP31 citations92
US5476847ADec 19, 1995
Derivatives of phosphinic acid useful as endothelin converting enzyme inhibitors
SCHERING CORP25 citations92
US6288068B1Sep 11, 2001
Muscarinic antagonists
SCHERING CORP22 citations91
US7662816B2Feb 16, 2010
Cyclic amine BACE-1 inhibitors having a benzamide substituent
SCHERING CORP11 citations84
US7713999B2May 11, 2010
Thrombin receptor antagonists
SCHERING CORP8 citations83
US6916811B2Jul 12, 2005
Adenosine A2a receptor antagonists
SCHERING CORP17 citations83
US6890936B2May 10, 2005
Muscarinic antagonists
SCHERING CORP9 citations74
US5506236AApr 9, 1996
4-substituted pyrazoloquinoline derivatives
SCHERING CORP7 citations74
US6897216B2May 24, 2005
Adenosine A2a receptor antagonists
SCHERING CORP5 citations73
US6498168B2Dec 24, 2002
Muscarinic antagonists
SCHERING CORP5 citations73
US7572802B2Aug 11, 2009
7-[2-[4-(6-fluoro-3-methyl-1,2-benzisoxazol-5-yl)-1-piperazinyl]ethyl]-2-(1-propynyl)-7H-pyrazolo-[4,3-e]-[1,2,4]-triazolo-[1,5-C]-pyrimidin-5-amine
SCHERING CORP7 citations71
US8022088B2Sep 20, 2011
Substituted bicyclic and tricyclic thrombin receptor antagonists
SCHERING CORP5 citations63
US8003803B2Aug 23, 2011
Fused ring thrombin receptor antagonists
SCHERING CORP4 citations63
US7888369B2Feb 15, 2011
Oxazoloisoquinoline derivatives as thrombin receptor antagonists
SCHERING CORP4 citations63
US7531544B2May 12, 2009
Xanthine phosphodiesterase V inhibitors
SCHERING CORP2 citations63
US7488742B2Feb 10, 2009
Thrombin receptor antagonists
SCHERING CORP5 citations63
US5459146AOct 17, 1995
4-substituted pyrazoloquinoline derivatives
SCHERING CORP5 citations63
US4740595AApr 26, 1988
Preparation of azetidinones via N-protected oxirancecarboxamide intermediates
SCHERING CORP2 citations63
US7713985B2May 11, 2010
Adenosine Aa2 receptor antagonists
SCHERING CORP4 citations62
US7709492B2May 4, 2010
Pyrazolo-[4,3-e]-1,2,4-triazolo-[1,5-c]-pyrimidine adenosine A2a receptor antagonists
SCHERING CORP2 citations62
US7465740B2Dec 16, 2008
2-heteroaryl-pyrazolo-[4,3-e]-1,2,4-triazolo-[1,5-c]-pyrimidine adenosine A2a receptor antagonists
SCHERING CORP3 citations62
US7368449B2May 6, 2008
2-alkynyl- and 2-alkenyl-pyrazolo-[4,3-e]-1,2,4-triazolo-[1,5-c]-pyrimidine adenosine A2a receptor antagonists
SCHERING CORP4 citations62
US7488752B2Feb 10, 2009
Thrombin receptor antagonists
SCHERING CORP6 citations60
US7442712B2Oct 28, 2008
Constrained himbacine analogs as thrombin receptor antagonists
SCHERING CORP6 citations60
US7268141B2Sep 11, 2007
Xanthine phosphodiesterase V inhibitors
SCHERING CORP4 citations60
CUMMING JARED N
2 patentsMERCK SHARP & DOHME
2 patentsSCHERING PLOUGH CORP
1 patent(unassigned)
1 patentXIA YAN
1 patentNEELAMKAVIL SANTHOSH FRANCIS
1 patentPHARMACOPEIA DRUG DISCOVERY
1 patentBOYLE CRAIG D
1 patentShowing the top 50 of 77 patents by PatentIndex Score.